awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42181037-416D7F63-9A49-44F9-9629-15EB85A9C451
Q42181037-416D7F63-9A49-44F9-9629-15EB85A9C451
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42181037-416D7F63-9A49-44F9-9629-15EB85A9C451
Emerging new therapeutic applications of capecitabine as a first-line chemotherapeutic agent in the management of advanced carcinomas other than colorectal carcinoma.
P2860
Q42181037-416D7F63-9A49-44F9-9629-15EB85A9C451
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42181037-416D7F63-9A49-44F9-9629-15EB85A9C451
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
612be52cbc2fd70473d3dd310276ddd833c1ca1d
P2860
A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients.